RARE
Ultragenyx Pharmaceutical Inc. · Healthcare
President and CEO Emil D Kakkis sold $1.4M of Ultragenyx Pharmaceutical Inc.
Sold$1,350,000
$45.00Price
30,000Shares
−1%Stake
What RARE did after the filing
- The stock from Thu, Feb 8 close, $45.45
- +0.9%
- S&P 500, same days
- +4.9%
Measured over 30 trading days, to the Mar 22 close.
Traded Wed, Feb 7. Filed Thu, Feb 8, 3:49 PM ET, during the session. Returns use the Feb 8 close and the Mar 22 close. Not investment advice.